B&C2: Treatments and drugs

0.0(0)
studied byStudied by 5 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/48

flashcard set

Earn XP

Description and Tags

star whichever ones actually feel relevant, i didn't know which to filter out

Last updated 1:12 PM on 10/19/25
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

49 Terms

1
New cards

Cessation

Detoxification when over-drank

2
New cards

Reverses Wernicke’s Encephelopathy

High-dose vitamin B1 injections

3
New cards

Treatment for alcohol

inpatient or outpatient addiction services 

4
New cards

Cure for Alzheimer’s

There is none.

5
New cards

Main diagnostic methods of Alzheimer’s

  • Neuropsychological assessment

  • Structural imaging

6
New cards

Drugs given for Alzheimer’s (2)

  • Cholinesterase inhibitors (stops loss of cholinergic neurons, improving communication between brain cells) 

  • Memantine (increases glutamate)

7
New cards

2 treatments for aneurysms (vascular cognitive impairment)

  • Endovascular treatment: such as coiling or stent placement, which are inserted into the blood vessel through the groin 

  • Neurosurgical intervention (clipping), where the aneurysm is closed with a metal clip

8
New cards

Cure for Parkinson’s 

No cure !!

9
New cards

Drugs for Parkinson’s (5)

  • Levodopa

  • Dopamine agonists

  • Monoamine oxidase type-B inhibitors

  • Amantadine 

  • Rivastigmine (for cognitive impairment)

10
New cards

Treatment for Parkinson’s (2)

→ deep brain stimulation (DBS) → implanting a thin wire with electrodes into the brain → high-frequency stimulation will alter the brain signals, leading to symptom improvement 

→ levodopa-carbiodopa intestinal gel (LCIG, brand name Duodopa)

  • administered as a gel directly into the first part of the small intestine, to offer more continuous dopaminergic stimulation leading to more constant levodopa levels

11
New cards

Types of atypical parkinsonisms

Lewy body dementia (LBD)

Corticobasal degeneration (CBD)
Multiple system atrophy (MSA)

Progressive supranuclear palsy (PSP)

12
New cards

Lewy body dementia (LBD) characteristics

Early dementia

Cognitive impairment

Hallucinations

Rigidity

Bradykinesia

(very Parkinson’s like)

13
New cards

Corticobasal degeneration (CBD) characteristics

Asymmetric motor symptoms

  • Alien hand

Apraxia

Cognitive deficits

14
New cards

Multiple system atrophy (MSA) characteristics

Erectile dysfunction

Incontinence (pee self)

Orthostatic hypotension (BP suddenly drops)

15
New cards

Progressive supranuclear palsy (PSP) characteristics

Axial rigidity

Disinhibition

Emotional instability

16
New cards

6 first-generation epilepsy drugs

Luminal

Diphantoin

Ethymal

Depakine

Frisium

Tegretol

side effects: decrease info processing speed, attention, and executive functions

17
New cards

10 second- generation epilepsy drugs

Taloxa

Neurontin

Lamictal

Topamax

Keppra

Trileptal

Sabril

Zonegran

Diacomit

Lyrcia

varying side effects

18
New cards

4 third-generation epilepsy drugs

Fycompa

Briviact

Inovelon

Vimpat

no major side effects! :)

19
New cards

Epilepsy treatments (3)

→ Wada test

→ Grid surgery

→ stereo EEG

20
New cards

Genetic disorder detectors (2)

Non-invasive prenatal test (NIPT, through blood tests), or a combined test (blood test and nuchal scan), enabling genetic abnormalities to be detected 


Whole-exome sequencing (WES) → examine entire genome for possible genetic variations 

21
New cards

Glasgow Coma Scale

measure cognitive dysfunctions after brain injury

22
New cards

Elaborate drawing test

Rey Figure Test

23
New cards

Scale to determine the severity of Parkinson’s symptoms

Hoehn and Yahr Scale

24
New cards

Hyposmia

fked sense of smell (Parkinson’s)

25
New cards

Ischemic core

Spot on brain with critically low blood flow that WILL die

26
New cards

Penumbra

Brain area around ischemic core

27
New cards

Diaschisis

Brain area being functionally disconnected because of the affected brain tissue

28
New cards

Temporal confusion

Loss of sense of time (in Korsakoff’s, this affect how they consolidate (and sequence) their memories)

29
New cards

Simulating (ch3)

pretending non-existing complaints

30
New cards

Aggravating (ch3)

exaggerating complaints

31
New cards

Sensitivity (ch3)

identifying people with a disease

32
New cards

Specificity (ch3)

identifying people without a disease

33
New cards

Problematic alcohol use

Physical/psychological/social problems regardless of quantity

34
New cards

Alcohol Use Disorder (AUD)

Problematic use meeting the DSM criteria

35
New cards

Binge drinking

Took much in a short period, but with abstinence phases (>5 for men, >4 for women)

36
New cards

Alcohol intoxication

Excessive use causing disorientation, less of consciousness, etc. (‘being rlly drunk’, one-time thing, consistent intoxication can lead to others)

37
New cards

Alcohol withdrawal syndrome

Sudden withdrawal after long-term use

38
New cards

Status epilepticus

seizure activity lasting more than 5 minutes or recurrent seizures without recovery

39
New cards

Order from most common to least:

Lewy Body Dementia, Alzheimer’s Dementia, Frontotemporal Dementia, Vascular Dementia

Most common: Alzheimer’s Disease

Vascular Dementia

Lewy Body Dementia

Least common: Frontotemporal Dementia

40
New cards

Order from most common to least:

Noonan, Klinefelter, Neurofibromatosis 1, Turner, Prader-Willi

Klinefelter (1:600)

Noonan (1:1,000–1:2,500)

Turner (1:2,000)

Neurofibromatosis 1 (1:3,000)

Prader–Willi (1:15,000)

41
New cards

Type 1 error vs Type 2 error

Type I error is a false positive (rejecting a true null hypothesis)

Type II error is a false negative (failing to reject a false null hypothesis)

42
New cards

What are 7 types of validity’s

Face validity

Content validity

Concept validity

Criterion validity

Predictive validity

Concurrent validity

Ecological validity

43
New cards

Face validity

on the surface, how well does the test seem to be measuring what it’s meant to

44
New cards

Content validity

How representative is the test of all relevant content

45
New cards

Concept/construct validity

how well does it measure the theoretical concept

46
New cards

Criterion validity

to what extend can a test predict a patient’s performance on an external criterion

47
New cards

Predictive validity

how well does a test actually predict behaviour

48
New cards

Concurrent validity

comparison between a neuropsychological test and another instrument that measure the same construct

49
New cards

Ecological validity

the extent to which the test predicts how a patient will function in their own daily environment